Seed grants foster collaboration across Cornell campuses

The funding will support preliminary disease-related research, in the latest in a series of efforts to create new opportunities for interdisciplinary research.

Harnessing AI technology for IVF embryo selection

An artificial intelligence algorithm can determine non-invasively, with about 70% accuracy, if an in vitro fertilized embryo has a normal or abnormal number of chromosomes, according to a new study from researchers at Weill Cornell Medicine.

Shielding likely reduced COVID exposure for pregnant people early in pandemic

Those already pregnant at the beginning of the pandemic had a 50% lower exposure to SARS-CoV-2 compared with those who became pregnant after the pandemic began and the general population, Weill Cornell researchers and colleagues found.

Top stories of 2022: COVID solutions, student heroics

The first recorded proof of a bird not seen for 140 years, a gut bacteria that could regulate cholesterol and a senior who risked his own life to rescue a man from an oncoming subway train were among the most-read Cornell Chronicle stories of 2022.

Potential therapy for aggressive type of colon cancer shows promise

An experimental therapy showed promise as treatment for an aggressively spreading type of colorectal cancer in preclinical models, according to a new study by Weill Cornell Medicine investigators.

Better digital tools could help immigrants access benefits

A Cornell research team identified barriers to immigrants’ use of online resources that could help them access health and legal benefits, and recommended solutions they incorporated into a new website, Rights for Health.

NIH funds antibiotic trial for HIV and emphysema

Weill Cornell Medicine has been awarded a five-year, $7.8 million grant from the National Heart, Lung, and Blood Institute to study whether the antibiotic doxycycline may slow the progression of emphysema in people living with well-controlled HIV.

Bacterium on International Space Station developing drug resistance

Acinetobacter pittii (A. pittii), a type of bacteria, is evolving to become more resistant to antibiotics and is finding ways to survive in the harsh environment of the International Space Station, according to new research led by Weill Cornell Medicine scientists.

Structural biology workshop builds intercampus connections

Cornell is creating unique opportunities for innovation in the rapidly evolving field of structural biology thanks to cutting-edge facilities and support for intercampus collaborations between Cornell's Ithaca campus and Weill Cornell Medicine.

Around Cornell